Glucagonoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Parminder Dhingra (talk | contribs)
No edit summary
Medhat (talk | contribs)
No edit summary
Line 3: Line 3:
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{PSD}}
==Overview==
==Overview==
The incidence of glucagonoma is approximately 0.0005 per 100,000 individuals worldwide.<ref name="pmid26248239">{{cite journal| author=Cardoso Filho Fde A, Feitosa RG, Fechine CO, Matos CM, Cardoso AL, Cardoso DL| title=Glucagonoma syndrome associated with necrolytic migratory erythema. | journal=Rev Assoc Med Bras | year= 2015 | volume= 61 | issue= 3 | pages= 203-6 | pmid=26248239 | doi=10.1590/1806-9282.61.03.203 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26248239  }} </ref> Glucagonoma affects men and women equally. The median age at diagnosis of glucagonoma is 52.5 years.
The incidence of glucagonoma is approximately 0.0005 per 100,000 individuals worldwide.  Glucagonoma affects men and women equally. The median age at diagnosis of glucagonoma is 52.5 years.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
*Fewer than 251 cases of glucagonoma have been described in the literature.<ref>Glucagonoma. Wikipedia. https://en.wikipedia.org/wiki/Glucagonoma. Accessed on October 13, 2015.</ref>
* Annual incidence is 0.01 to 0.1 new cases per 100,000.1
*The incidence of glucagonoma is approximately 0.0005 per 100,000 individuals worldwide.<ref name="pmid26248239">{{cite journal| author=Cardoso Filho Fde A, Feitosa RG, Fechine CO, Matos CM, Cardoso AL, Cardoso DL| title=Glucagonoma syndrome associated with necrolytic migratory erythema. | journal=Rev Assoc Med Bras | year= 2015 | volume= 61 | issue= 3 | pages= 203-6 | pmid=26248239 | doi=10.1590/1806-9282.61.03.203 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26248239  }} </ref>
 
*The median age at diagnosis of glucagonoma is 52.5 years.
* While most glucagonomas are sporadic, up to 20 percent may be associated with the multiple endocrine neoplasia syndrome type 1 (MEN1).  
* However, glucagonomas occur in only 3 percent of MEN1 patients [3].
 
* Patients typically present in their fifth decade [2].
 
*Fewer than 251 cases of glucagonoma have been described in the literature.
*Glucagonoma affects men and women equally.
*Glucagonoma affects men and women equally.



Revision as of 20:03, 1 August 2017

Glucagonoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Glucagonoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glucagonoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glucagonoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glucagonoma epidemiology and demographics

CDC on Glucagonoma epidemiology and demographics

Glucagonoma epidemiology and demographics in the news

Blogs on Glucagonoma epidemiology and demographics

Directions to Hospitals Treating Glucagonoma

Risk calculators and risk factors for Glucagonoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

The incidence of glucagonoma is approximately 0.0005 per 100,000 individuals worldwide. Glucagonoma affects men and women equally. The median age at diagnosis of glucagonoma is 52.5 years.

Epidemiology and Demographics

  • Annual incidence is 0.01 to 0.1 new cases per 100,000.1
  • While most glucagonomas are sporadic, up to 20 percent may be associated with the multiple endocrine neoplasia syndrome type 1 (MEN1).
  • However, glucagonomas occur in only 3 percent of MEN1 patients [3].
  • Patients typically present in their fifth decade [2].
  • Fewer than 251 cases of glucagonoma have been described in the literature.
  • Glucagonoma affects men and women equally.

References


Template:WikiDoc Sources